Here's my 2 cents to go along with the above post
1. This statement 'The days of $200,000 device jobs are over anywhere' is inaccurate. Check Acclarent, Urolift, or Intersect just to name a few. They are out there but you better believe there is pressure to perform. You don't sell, you don't get paid, and you won't be around for long. High risk- high reward. Let's face it $200,000 shouldn't come that easy assholes.
2.The company is transitioning... I wouldn't say transitioning to a device company- check the pipeline- but to a women's health company that sells a procedural device and of course IUDs.
3. Here are the issues: Quotas- were to high in the first half of the 2014. They have been adjusted now and even at CPTS a minimum of 20% growth for Essure was expected to meet the goal. Another issue is the mindset of reps- There are many Bayer legacy reps that are having a hard time thinking for themselves - no offense here. They have been with Bayer and selling in a pharma model for 7, 12, or 18 years and are stuck in the habit of hallway calls and lunches repeating the latest pitch and pt type from marketing. We all need to do somethings different and changing the way we sell is one of them. There are also many legacy CPTS reps who need development and need to suck it up, accept the hand that has been dealt and seize the opportunity to work with an organization such as Bayer or find an opportunity that is right for them (see above companies).
We'll get it right eventually, just need to give it some time and challenge ourselves to think differently both in Whippany and in the field.